
Investment firm partnering with venture and growth funds to gain exposure to Chinese companies

Biomedical venture capital firm investing in drug, device and diagnostics companies from offices in Asia and California

Lilly Asia Ventures, known as LAV, is a biomedical venture capital firm. It says it wants to be a long-term partner for entrepreneurs building companies that develop products to treat disease and improve health.
Entrepreneurs seeking patient, long-term capital and scientific rigour. The firm describes its philosophy as backing people, products and quality science, and combines domain expertise with a global network.
Summary written by TrustList from the business's own published information, Oct 2026.
1 image - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Lilly Asia Ventures.
Similar listings buyers compare against this one.

Investment firm partnering with venture and growth funds to gain exposure to Chinese companies

Africa-focused investor that funds and mentors entrepreneurs, backed by the Chandaria Group of Companies

Venture firm investing in software and hardware startups for architecture, engineering and construction

US-based network of private equity and venture capital firms with offices across North America, Asia and Europe

Early-stage venture firm backing enterprise-focused start-ups and linking them with Asian corporate partners

Venture arm investing in American medical device startups and linking them to Japanese partners

Healthcare venture investor backing medical device and biotechnology companies through funding rounds

Indianapolis private investment firm that buys and permanently holds companies from owner-operators
Everything here links back to the same verified catalogue. Pick your next stop.